Vaishali Pharma Limited (VAISHALI) — Cash Flow-to-Debt Ratio
Vaishali Pharma Limited (VAISHALI) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of Rs20.46 Million could theoretically repay 0% of its total liabilities (Rs545.40 Million) in one year. See Vaishali Pharma Limited financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vaishali Pharma Limited Cash Flow-to-Debt Ratio (2013–2026)
Historical debt coverage capacity for Vaishali Pharma Limited across 14 annual periods. For the full cash flow conversion analysis, see Vaishali Pharma Limited (VAISHALI) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Vaishali Pharma Limited (2013–2026)
Year-by-year debt coverage analysis for Vaishali Pharma Limited. Check Vaishali Pharma Limited cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.01x | Rs4.36 Million | Rs542.74 Million | ▲ +102.0% |
| 2025 | -0.40x | Rs-180.38 Million | Rs449.29 Million | ▼ -1947.2% |
| 2024 | 0.02x | Rs8.07 Million | Rs371.16 Million | ▼ -22.7% |
| 2023 | 0.03x | Rs10.80 Million | Rs383.76 Million | ▲ +17.9% |
| 2022 | 0.02x | Rs13.19 Million | Rs552.70 Million | ▼ -24.4% |
| 2021 | 0.03x | Rs20.11 Million | Rs637.05 Million | ▼ -56.0% |
| 2020 | 0.07x | Rs32.19 Million | Rs448.23 Million | ▲ +19.4% |
| 2019 | 0.06x | Rs28.48 Million | Rs473.52 Million | ▲ +127.8% |
| 2018 | -0.22x | Rs-94.60 Million | Rs437.22 Million | ▼ -1135.9% |
| 2017 | 0.02x | Rs8.52 Million | Rs407.80 Million | ▼ -78.8% |
| 2016 | 0.10x | Rs45.88 Million | Rs465.19 Million | ▲ +213.0% |
| 2015 | -0.09x | Rs-37.16 Million | Rs425.60 Million | ▲ +37.5% |
| 2014 | -0.14x | Rs-70.40 Million | Rs503.56 Million | ▼ -268.7% |
| 2013 | 0.08x | Rs37.97 Million | Rs458.09 Million | — |